Investment augments CorEvitas’ pharmacovigilance services to fulfill global regulatory requirements for the safety of medications and vaccines during pregnancy
Waltham, MA and Los Angeles, CA, November 22, 2022 – CorEvitas, LLC (“CorEvitas”), an industry leader in syndicated registries,...Learn More
Waltham, MA and London, UK, July 6, 2022 — CorEvitas, LLC is excited to announce expanded services to include specialty EMR data through its Specialty EMR Data Business Unit. Health iQ Limited, a subsidiary of CorEvitas, has provided innovative real-world evidence solutions in...Learn More
Panelists explore how connecting claims and clinical registry data lead to a better understanding of the patient journey
Waltham, MA and Bowie, MD, May 11, 2022—CorEvitas, LLC, the built-for-purpose provider of real-world evidence, and Inovalon, a leading...Learn More
CEO Ray Hill Speaks with Pharma Exec about Understanding Real-World Data, Real-World Evidence, & Their Use.
Watch here: https://www.pharmexec.com/view/understanding-real-world-evidence-...Learn More